Hypoxia-induced HIF-1 α accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: Involvement of ERK1/2 and PI-3K/Akt

Experimental Cell Research

Volumn 312, Issue 2, 2006, Pages 145-155

  Zhang, Qunzhou ^a   Oh, Chad K ^b   Messadi, Diana V ^c   Duong, Hai S ^c   Kelly, A Paul ^d   Soo, Chia ^e   Wang, Lina ^d   Le, Anh D ^a,f  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cell cell interaction; ERK1 2; HIF 1 ; HMC 1; Hypoxia; Keloid fibroblasts; PI 3K Akt

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; VASCULOTROPIN;

ARTICLE; CELL CONTACT; CELL CULTURE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; KELOID; MAST CELL; POROSITY; PRIORITY JOURNAL;

EID: 28344454083     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.10.006     Document Type: Article

References (65)

1. F.B. Niessen, P.H.M. Spauwen, J. Schalkwijk, and K.K. Moshe On the nature of hypertrophic scars and keloids: a review Plast. Reconstr. Surg. 104 1999 1435 1458
2. C.W. Kischer, A.C. Thies, and M. Chvapil Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids Hum. Pathol. 13 1982 819 824
3. C.W. Kischer The microvessels in hypertrophic scars, keloids and related lesions: a review J. Submicrosc. Cytol. Pathol. 24 1992 281 296
4. R.B. Berry, O.T. Tan, E.D. Cooke, P.M. Gaylarde, S.A. Bowcock, B.G. Lamberty, and M.E. Hackett Transcutaneous oxygen tension as an index of maturity in hypertrophic scars treated by compression Br. J. Plast. Surg. 38 1985 163 173
5. T.W. Beer, H.C. Baldwin, J.R. Goddard, P.J. Gallagher, and D.H. Wright Angiogenesis in pathological and surgical scars Hum. Pathol. 29 1998 127 1278
6. A.P. Kelly, P. Zheng, and B.L. Johnson Mast cells and keloid formation J. Invest. Dermatol. 106 1996 838 841
7. I. Appleton, N.J. Brown, and D.A. Willoughby Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids Am. J. Pathol. 149 1996 1441 1447
8. A. Le, Q. Zhang, Y. Wu, D.V. Messadi, T.L. Aghaloo, A. Akhondzadeh, A.P. Kelly, and C.N. Bertolami Elevated VEGF in keloids: relevance to tissue fibrosis Cells Tissues Organs 176 2004 87 94
9. M. Detmar, L.F. Brown, B. Berse, R.W. Jackman, B.M. Elicker, H.F. Dvorak, and K.P. Claffey Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin J. Invest. Dermatol. 108 1997 263 268
10. D.S. Steinberg, M.T. Longaker, B.J. Mehrara, P.B. Saadeh, G.S. Chin, R.P. Gerrets, D.C. Chau, N.M. Rowe, and G.K. Gittes Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation J. Surg. Res. 84 1999 127 133
11. D.D. Metcalfe, D. Baram, and Y.A. Mekori Mast cells Physiol. Rev. 77 1997 1033 1070
12. H.P. McNeil The mast cell and inflammation Aust. N.Z. J. Med. 26 1996 216 225
13. J.A. Cairns, and A.F. Walls Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts J. Clin. Invest. 99 1997 1313 1321
14. D.J. Farrell, J.E. Hines, A.F. Walls, P.J. Kelly, M.K. Bennett, and A.D. Burt Intrahepatic mast cells in chronic liver diseases Hepatology 22 1995 1175 1181
15. F. Levi-Schaffer, and A.M. Piliponsky Tryptase, a novel link between allergic inflammation and fibrosis Trends Immunol. 24 2003 158 161
16. C. Benoist, and D. Mathis Mast cells in autoimmune disease Nature 420 2002 875 878
17. I. Puxeddu, A.M. Piliponsky, I. Bachelet, and F. Levi-Schaffer Mast cells in allergy and beyond Int. J. Biochem. Cell Biol. 35 2003 1601 1607
18. K.L. Choi, and H.N. Claman Mast cells, fibroblasts and fibrosis: new clues to the riddle of mast cells Immunol. Res. 6 1987 145 152
19. M. Artuc, B. Hermes, U.M. Stechelings, A. Grutzkau, and B.M. Henz Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders? Exp. Dermatol. 8 1999 1 16
20. M. Huttunen, M.L. Aalto, R.J. Harvima, M. Horsmanheimo, and I.T. Harvima Alterations in mast cells showing tryptase and chymase activity in epithelialization and chronic wounds Exp. Dermatol. 9 2000 258 265
21. C.W. Kischer, H. Bunce, and M.R. Shetlah Mast cell analyses in hypertrophic scars, hypertrophic scars treated with pressure and mature scars J. Invest. Dermatol. 70 1978 355 361
22. Y.S. Lee, and S. Vijayasingam Mast cells and myofibroblasts in keloid: a light microscopic, immunohistochemical and ultrastructural study Ann. Acad. Med. Singap. 24 1995 902 905
23. C.J. Smith, and M.C. Finn The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring J. Burn. Care Rehabil. 8 1987 126 131
24. S.S. Craig, G. DeBlois, and L.B. Schwartz Mast cells in human keloid, small intestine, and lung by an immunoperoxidase technique using a murine monoclonal antibody against tryptase Am. J. Pathol. 124 1986 427 435
25. M. Ivan, K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J.M. Asara, W.S. Lane, and W.G. Kaelin Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing Science 292 2001 464 468
26. P. Jaakkola, D.R. Mole, Y.M. Tian, M.I. Wilson, J. Gielbert, S.J. Gaskell, A.V. Kriegsheim, H.F. Hebestreit, M. Mukherji, C.J. Schofield, P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation Science 292 2001 468 472
27. T. Hellwig-Burgel, K. Rutkowski, E. Metzen, J. Fandrey, and W. Jelkmann Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1 Blood 94 1999 1561 1567
28. J.E. Albina, B. Mastrofrancesco, J.A. Vessella, C.A. Louis, W.L. Henry Jr., and J.S. Reichner HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha Am. J. Physiol.: Cell Physiol. 281 2001 C1971 C1977
29. J.J. Haddad, and S.C. Land A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1 alpha FEBS Lett. 505 2001 269 274
30. J.J. Haddad, and H.L. Harb Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α Int. Immunopharm. 5 2005 461 483
31. Y. Jung, J.S. Isaacs, S. Lee, J. Trepel, Z.G. Liu, and L. Neckers Hypoxia-inducible factor induction by tumor necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation Biochem. J. 370 2003 1011 1017
32. J. Zhou, J. Fandrey, J. Schumann, G. Tiegs, and B. Brune NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells Am. J. Physiol.: Cell Physiol. 284 2003 C439 C446
33. Y.J. Jung, J.S. Isaacs, S. Lee, J.J. Trepel, and L. Neckers IL-1β-mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J. 17 2003 2115 2117
34. T. Cramer, and R.S. Johnson A novel role for the hypoxia inducible transcription factor HIF-1α: critical regulation of inflammatory cell function Cell Cycle 2 2003 192 193
35. J. Karhausen, V.H. Haase, and S.P. Colgan Inflammatory hypoxia: role of hypoxia-inducible factor Cell Cycle 4 2005 256 258
36. Q. Zhang, Y. Wu, D.K. Ann, D.V. Messadi, T.L. Tuan, A.P. Kelly, C.N. Bertolami, and A. Le Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts J. Invest. Dermatol. 121 2003 1005 1012
37. Y. Wu, Q. Zhang, D.K. Ann, A. Akhondzadeh, H.S. Duong, D.V. Messadi, and A. Le Increased vascular endothelial growth factor may account for an elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts Am. J. Physiol.: Cell Physiol. 286 2004 C905 C912
38. Q. Zhang, Y. Wu, C.H. Chau, D.K. Ann, C.N. Bertolami, and A. Le Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts J. Cell. Physiol. 199 2004 89 97
39. S. Suzuki, M. Sato, H. Senoo, and K. Ishikawa Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP Exp. Cell Res. 293 2004 259 266
40. M. Alexandrakis, R. Letourneau, D. Kempuraj, K. Kandere-Grzybowska, M. Huang, S. Christodoulou, W. Boucher, D. Seretakis, and T.C. Theoharides Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1) Eur. J. Haematol. 71 2003 448 454
41. D.V. Messadi, A. Le, S. Berg, A. Jewett, Z. Wen, P. Kelly, and C.N. Bertolami Expression of apoptosis-associated genes by human dermal scar fibroblasts Wound Repair Regen. 7 1999 511 517
42. T. Cramer, Y. Yamanishi, B.E. Clausen, I. Forster, R. Pawlinski, N. Mackman, V.H. Haase, R. Jaenisch, M. Corr, V. Nizet, G.S. Firestein, H.P. Gerber, N. Ferrara, and R.S. Johnson HIF-1alpha is essential for myeloid cell-mediated inflammation Cell 112 2003 645 657
43. K.B. Sandau, J. Fandrey, and B. Brune Accumulation of HIF-1α under the influence of nitric oxide Blood 97 2001 1009 1015
44. K.B. Sandau, H.G. Faus, and B. Brune Induction of hypoxia-inducible- factor-1 by nitric oxide is mediated via PI 3K pathway Biochem. Biophys. Res. Commun. 278 2000 263 267
45. J.H.W. Distler, R.H. Wenger, M. Gassmann, M. Kurowska, A. Hirth, S. Gay, and O. Distler Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis Arthritis Rheum. 50 2004 10 23
46. A. Giatromanolaki, E. Sividis, E. Maltezos, N. Athanassou, D. Papazoglou, K.C. Gatter, A.L. Harris, and M.I. Koukourakis Upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritis Arthritis Res. Ther. 5 2003 R193 R201
47. A.P. Hollander, K.P. Corke, A.J. Freemont, and C.E. Lewis Expression of hypoxia-inducible factor-1α by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joints Arthritis Rheum. 44 2001 1540 1544
48. C.L. Peters, C.J. Morris, P.I. Mapp, D.R. Blake, C.E. Lewis, and V.R. Winrow The transcription factors hypoxia-inducible factor-1α and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis Arthritis Rheum. 50 2004 291 296
49. S. Kokura, N. Yoshida, and T. Yoshikawa Anoxia/reoxygenation-induced leukocyte-endothelial cell interactions Free Radic. Biol. Med. 33 2002 427 432
50. J.S. Lewis, J.A. Lee, J.C. Underwood, A.L. Harris, and C.E. Lewis Macrophage responses to hypoxia: relevance to disease mechanisms J. Leuko. Biol. 66 1999 889 900
51. D.E. Woolley The mast cell in inflammatory arthritis N. Engl. J. Med. 348 2003 1709 1711
52. T.W. Beer, H. Baldwin, L. West, J. Gallagher, and D.H. Wright Mast cells in pathological and surgical scars Br. J. Ophthalmol. 82 1998 691 694
53. A. Trautmann, B. Feunerstein, N. Ernst, E.B. Bröcker, and C.E. Klein Heterotypic cell-cell adhesion of human mast cells to fibroblasts Arch. Dermatol. Res. 289 1997 194 203
54. A. Trautmann, G. Krohne, E.B. Bröcker, and C.E. Klein Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4 J. Immunol. 160 1998 5053 5057
55. M. Abe, M. Kurosawa, O. Ishikawa, Y. Miyachi, and H. Kido Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production Clin. Exp. Allergy 28 1998 150 1517
56. C.M. Skold, Y. Ohkuni, X.D. Liu, R. Numerof, and S.I. Rennard Co-cultured human mast cells stimulate fibroblast-mediated contraction of collagen gels Inflammation 25 2001 47 51
57. M. Artuc, U.M. Steckelings, and B.M. Henz Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors J. Invest. Dermatol. 118 2002 391 395
58. S.M. Fitzgerald, S.A. Lee, H.K. Hall, D.S. Chi, and G. Krishnaswamy Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact Am. J. Respir. Cell. Mol. Biol. 30 2004 585 593
59. E.M. Comerford, E.P. Cummins, and C.T. Taylor C-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor-1α-dependent P-glycoprotein expression in hypoxia Cancer Res. 64 2004 9057 9061
60. L. Xu, P.S. Pathak, and D. Fukumura hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol-3′-kinase signaling pathways contributes too expression of interleukin 8 in human ovarian carcinoma cells Clin. Cancer Res. 10 2004 701 707
61. H.J. Jeong, J.-B. Kim, S.-H. Hong, N.-H. An, M.-S. Kim, B.-R. Park, R.-K. Park, and H.-M. Kim Vascular endothelial growth factor is regulated by hypoxic stress via MAPK and HIF-1α in the inner ear J. Neuroimmunol. 163 2005 84 91
62. S. Adachi, Y. Ebi, S. Nishikawa, S. Hayashi, M. Yamazaki, T. Kasugai, T. Yamamura, S. Nomura, and Y. Kitamura Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts Blood 79 1992 650 656
63. T. Yamamoto, K. Hartmann, B. Eckes, and T. Krieg Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interactions: role of stem cell factor/c-kit Immunology 99 2000 435 439
64. A. Ito, T. Jippo, and T.T. Wakayama SgIGSF: a new mast-cell adhesion molecule used for attachment to fibroblasts and transcriptionally regulated by MITF Blood 101 2003 2601 2608
65. Y. Koma, A. Ito, K. Watabe, T. Hirata, M. Mizuki, H. Yokozaki, T. Kitamura, Y. Kanakura, and Y. Kitamura Distinct role for c-kit receptor tyrosine kinase and SgIGSF adhesion molecule in attachment of mast cells to fibroblasts Lab. Invest. 85 2005 426 435